Literature DB >> 14763910

Advances in diagnostic practices affect thyroid cancer incidence in France.

L Leenhardt1, M O Bernier, M H Boin-Pineau, B Conte Devolx, R Maréchaud, P Niccoli-Sire, M Nocaudie, J Orgiazzi, M Schlumberger, J L Wémeau, L Chérie-Challine, F De Vathaire.   

Abstract

OBJECTIVE: To analyse trends in diagnostic practices of thyroid diseases and to relate them to the increase in thyroid cancer incidence in France over time.
DESIGN: From 1980 to 2000, a French retrospective multicentric (three endocrinology and three nuclear medicine centres) study of thyroid diseases was conducted on 20 consecutive unselected patients' records, sampled every 5 years in each centre.
METHODS: Characteristics of the population and diagnosis procedures (thyroid ultrasonography (US), radionuclide scan, cytology and hormonal measurements) were described over time. Changing trends in operated patients and in cancer prevalence were analysed as well as the impact of practices on cancer incidence.
RESULTS: The study included 471 patients (82% female, mean age 46.7, range 9-84 years), referred for nodular thyroid diseases (66.7%) or thyroid dysfunctions (33.3%). A significant increase in US (3 to 84.8%) and cytological practices (4.5 to 23%), and a decrease (89.4 to 49.6%) in radionuclide scan procedures were observed over time. Although the proportion of patients undergoing surgery remained constant (24.8%), the prevalence of cancer increased among operated patients from 12.5 to 37% (P=0.006). In a Cox's proportional hazard model stratified on the clinical characteristics of patients, only the cytological practice, regardless of its results, was significantly associated with the occurrence of cancer: relative risk (RR)=4.4 (95% confidence interval (CI): 1.1-16; P=0.04).
CONCLUSIONS: From 1980 to 2000, a major evolution in clinical practices has led to the increase in thyroid cancer reported in France. Such changes in medical, as well as in surgical and pathological, practices must be taken into account in incidence measurement.

Entities:  

Mesh:

Year:  2004        PMID: 14763910     DOI: 10.1530/eje.0.1500133

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  56 in total

1.  Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006.

Authors:  Oladejo Olaleye; Udeme Ekrikpo; Ram Moorthy; Owen Lyne; Jill Wiseberg; Myles Black; David Mitchell
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-12       Impact factor: 2.503

2.  The role of preoperative neck ultrasounds to assess lymph nodes in patients with suspicious or indeterminate thyroid nodules.

Authors:  Rashmi Roy; Guennadi Kouniavsky; Raghunandan Venkat; Erin A Felger; Zita Shiue; Eric Schneider; Martha A Zeiger
Journal:  J Surg Oncol       Date:  2011-10-17       Impact factor: 3.454

Review 3.  Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.

Authors:  M G Castagna; S Cantara; F Pacini
Journal:  J Endocrinol Invest       Date:  2016-06-27       Impact factor: 4.256

4.  Causes of referral to the first endocrine visit of patients with thyroid carcinoma in a mildly iodine-deficient area.

Authors:  Michela Marina; Gian Paolo Ceda; Raffaella Aldigeri; Graziano Ceresini
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

5.  Thyroid cancer: incidence and mortality trends in China, 2005-2015.

Authors:  Junyi Wang; Fangfang Yu; Yanna Shang; Zhiguang Ping; Li Liu
Journal:  Endocrine       Date:  2020-01-30       Impact factor: 3.633

Review 6.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

7.  Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination.

Authors:  Pasqualino Malandrino; Marco Russo; Anna Ronchi; Claudio Minoia; Daniela Cataldo; Concetto Regalbuto; Carla Giordano; Marco Attard; Sebastiano Squatrito; Francesco Trimarchi; Riccardo Vigneri
Journal:  Endocrine       Date:  2015-10-05       Impact factor: 3.633

8.  Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  Bone       Date:  2014-12-11       Impact factor: 4.398

9.  Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma.

Authors:  Sara E Murray; David F Schneider; Philip S Bauer; Rebecca S Sippel; Herbert Chen
Journal:  J Am Coll Surg       Date:  2013-03-20       Impact factor: 6.113

10.  Telomeres and thyroid cancer.

Authors:  Marco Capezzone; Stefania Marchisotta; Silvia Cantara; Furio Pacini
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.